- In October 2024, First Response launched the Multi Check Pregnancy Test Kit with an EasyCup, which combines a sample collection cup with an integrated test strip to simplify the testing process. This innovation improves user experience by offering multiple testing options and meeting consumer preferences for ease and control. The launch is expected to boost demand for pregnancy test kits by enhancing convenience and accessibility, aligning with the growing trend for at-home diagnostic solutions in the women’s health diagnostics market
- In October 2024, Yourgene Health and Genetix introduced Colombia's first local non-invasive prenatal testing (NIPT) service, using Yourgene's IONA Nx NIPT Workflow. This service provides rapid and accurate results for expectant parents, reducing reliance on overseas testing and lowering associated costs. The launch is poised to drive growth in the prenatal testing segment by making NIPT more accessible and affordable in Colombia, fostering greater market penetration in Latin America
- In June 2023, Salignostics launched its innovative Salistick saliva pregnancy test in the UK, providing an alternative to traditional urine tests. The device detects hCG hormone through a saliva sample and delivers results in just 5 to 15 minutes. This innovation is expected to impact the market by offering a more comfortable, convenient, and non-invasive testing method, meeting the growing demand for alternative and user-friendly diagnostic solutions in women’s health
- In September 2021, Terumo Aortic had announced the start of PANTHER, the company's global surgical transplant research. This prospective and retrospective multi-center, multi-arm post-market study looks at the company's whole line of knitted and woven surgical grafts and cardiovascular patches
- In June 2021, Illumina and Next Generation Genomic Thailand launched the VeriSeq NIPT Solution v2 for non-invasive prenatal testing in Thailand. This CE-IVD solution offers comprehensive fetal genome insights, detecting chromosomal anomalies beyond standard tests, and enables testing as early as 10 weeks via a single blood draw. The introduction of this advanced solution is expected to strengthen the prenatal testing market in Southeast Asia, enhancing the quality of pregnancy management and expanding access to high-precision diagnostic tools in the region
